Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Bharat Parenterals Limited (NSE: BPLPHARMA), ISIN INE365Y01019 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BPLPHARMA last traded at ₹1841.90 (-2.13%), with a 52-week range of ₹1125.70 to ₹2295.10 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 67.20%, FIIs 0.11%, DIIs 1.29%, mutual funds 0.07%.
EquiSense Score (ECS): 81/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.